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An Efficient Method for Isolating Antibody Fragments Against Small 
Peptides by Antibody Phage Display 
Zhi Duan and Henrik Siegumfeldt
*
 
Department of Food Science, Faculty of Life Sciences, The University of Copenhagen, Denmark 
Abstract: We generated monoclonal scFv (single chain variable fragment) antibodies from an antibody phage display 
library towards three small synthetic peptides derived from the sequence of ?s1-casein. Key difficulties for selection of 
scFv-phages against small peptides were addressed. Small peptides do not always bind efficiently to passive adsorption 
surfaces, and we developed a simple method to quantify the binding capacity of surfaces with the peptides. Background 
binding (the binding of scFvs to the background matrix) is an obstacle for successful selection, and we evaluated two 
methods that drastically reduced the background binding. An optimized method therefore enabled a panning procedure 
where the specific (peptide binding) scFv-phages were always dominant. Using 15-mer peptides immobilized on Nunc 
Immobilizer Streptavidin plates, we successfully generated scFvs specifically against them. The scFvs were sequenced 
and characterized, and specificity was characterized by ELISA. The methods developed in this study are universally 
applicable for antibody phage display to efficiently produce antibody fragments against small peptides. 
Keywords: Phage display, scFv, Tomlinson I + J libraries, casein, peptide. 
INTRODUCTION 
 Anti-peptide antibodies or antibody derivates have a 
number of uses in biological research and bioassay, which 
can be applied for the identification, quantification and 
purification of proteins containing the peptide sequence 
chosen [1-3]. Due to the precise epitope location on native 
proteins recognized by anti-peptide antibodies, some 
investigators used them for the specific applications, such as 
to block adherence of cells [4], to inhibit enzyme activity [5, 
6], to detect receptor binding region of target proteins [7], 
and to detect proteolysis [8, 9]. Compared to anti-protein 
antibodies, anti-peptide antibodies are more useful for 
protein-protein interaction study, because peptide antigen 
sequences are already defined and antibody sequences can be 
simply obtained by sequencing of monoclonal antibody 
genes. The antibodies directly produced by using peptides as 
antigens also save much time for epitope mapping. 
 The conventional method for producing antibodies is 
called hybridoma technology [10], by which monoclonal 
antibodies are obtained from immunized animals with a 
purified antigen. The methods for producing antibodies have 
been revolutionized in the last decades. The manipulation of 
genes encoding antibodies allowed to successfully construct 
antibody derivates, which retain full antigen binding 
function, e.g. single-chain variable antibody fragment (scFv) 
[11]. Functional scFv expressed from a single cDNA 
sequence can be produced efficiently in bacteria without the 
need to immunize animals [12]. Since the pioneering work of 
Smith [13] and development by Mccafferty et al. [14], the 
expression of scFvs on the surface of phage and panning of 
these phage libraries against target antigen has matured into 
an extensively used technique to produce recombinant 
antibodies for research purposes and for the development of 
therapeutics [15, 16]. The production and selection of scFvs 
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on phage surface is much faster compared to conventional 
hybridoma technique. The availability of large and diverse 
antibody gene repertoires in phage [17, 18] has provided a 
source of scFvs to almost any antigens. The antibodies 
produced by hybridoma technology as animal antibodies 
immunogenic for human cannot be directly used as 
therapeutic agents, whereas human antibody libraries can be 
established on the phage surface [19, 20]. Furthermore, 
affinity maturation (increasing the affinity and specificity) of 
recombinant antibodies is applicable and simple by using 
antibody phage libraries [21, 22]. 
 The primary aim of this study was to select antibodies 
(scFvs) against small peptide fragments by antibody phage 
display. These peptide sequences traverse cleavage sites of 
different enzymes responsible for cheese ripening. The 
selected antibodies can subsequently be utilized in studies of 
cheese ripening, as the antibodies will bind to the intact 
peptide sequence, but after cleavage by enzymes, the 
antibody can no longer recognize the substrate. 
 Selection of scFv-phage libraries against big proteins is 
rather straightforward. In contrast, selection against small 
peptides has two primary challenges: (1) Efficient 
immobilization of peptides on solid surface, (2) Reduction of 
background binding scFv-phages. Background binding is the 
binding of scFvs to the background matrix (e.g., blocking 
proteins, or empty solid surface). In addition, as our target 
antigens are fragments from milk (?s1-CN), the most popular 
blocking reagent, skim milk solution, was not applicable. In this 
study we solved the above difficulties and succeeded in 
generating scFv-phages against synthetic peptide fragments from 
?s1-CN by selection of Tomlinson I + J scFv-phage libraries. 
MATERIALS & METHODS 
scFv-Phage Library, Bacteria, and Reagents 
 The Human Single Fold scFv libraries I + J (Tomlinson I 
+ J), E. coli TG1 and KM13 helper phage [23] were kindly 
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provided by MRC Centre (Cambridge, UK). All types of 96 
well microplates were from Nunc A/S (Roskilde, Denmark). 
The HRP/anti-M13 phage conjugated antibody was from GE 
Healthcare. Unless otherwise stated, all the other commonly 
used reagents were from Sigma-Aldrich. 
Introduction to Tomlinson I + J Libraries 
 Tomlinson I + J libraries are synthetic libraries displayed 
on M13 filamentous phage. 18 different amino acid positions 
in the antigen-binding sites are mutated to construct the 
highly diverse repertoire [24]. Two different mutation 
strategies result in library sizes of 1.47?108 (Library I) and 
1.37?108 (Library J) [24]. The scFv-phage in Tomlinson I + 
J libraries is monomeric, which in practice means that only 
one copy of scFv is attached on each phage [25]. The bound 
phage can be easily eluted, because the c-myc epitope tag 
cleavable by trypsin is introduced between the scFv and pIII 
(phage coat protein) [26]. A successful multiplication of 
scFv-phages in the host requires the presence of a helper 
phage. The KM13 helper phage has another trypsin cleavage 
site in the engineered pIII, which renders KM13 non-
infective after trypsin treatment [23],
 
whereas the scFv-pIII 
fusion loses scFv protein but remains infective. The non-
specific binding population in eluted phage is therefore 
dramatically reduced by trypsin treatment compared with the 
traditional eluting method (e.g., triethylamine eluting) in 
phage display panning [26, 27]. 
Synthetic Peptides 
 Three peptides were selected from ?s1-CN sequence 
(Table 1) named F1, F2 and F3, respectively. The peptides 
(including the biotinylated) were synthesized at 80% purity 
by JPT Peptide Technologies GmbH, Berlin, Germany. 
 E. coli TG1 growth and scFv-phage production is 
2?TY media [16 g/l Tryptone (hydrolyzed caseins), 10 g/l 
yeast Extract, 5 g/l NaCl]. We replaced T/l yeast Extract, 5 
g/l NaCl]. We replaced Tryptone with Peptone (Bacto), 
hereafter named PY medium. This replacement did not affect 
the growth (results not shown). The reason for the 
replacement was that we wanted to select scFvs against 
casein fragments, and Tryptone is a hydrolysate of casein, 
whereas Peptone is hydrolysate of animal tissue. 
Immobilization Mechanism of Different Solid Surfaces 
 Immo-Amino incorporates amine reactive moieties that 
react with nucleophiles (e.g. primary amines and thiols) of 
proteins/peptides and thereby causes covalent 
immobilization. Immo-Strep utilises the strong interaction 
between streptavidin and biotinylated specific antigens.  
 
Because the basic material of these reactive surfaces is 
Polysorp, intermolecular attraction forces caused by 
hydrophobic binding can also happen (Nunc Technical 
Bulletin No. 6, Nunc Tech Note Vol. 6 No. 41 and 43). 
Maxisorp is a passive adsorption surface without reactive 
moieties. 
Immobilization of Peptides or Proteins on Different Solid 
Surfaces 
 Unless otherwise stated, all the proteins or peptides had 
the following concentrations for binding: peptides (non-
modified and biotinylated) 20 μg/ml, ?s-Casein 500 ug/ml, 
Casein and BSA 1 mg/ml, fish gelatin 5 mg/ml. 
 Maxisorp: The peptides or proteins in PBS buffer (5.84 
g/l NaCl, 4.72 g/l Na2HPO4 and 2.64 g/l NaH2PO4.2H20, pH 
7.2) were incubated overnight at 4°C. 
 Immo-Amino: The peptides in Na carbonate buffer 
(Na2CO3 3.18 g/l, NaHCO3 5.86 g/l, pH 9.6) or proteins in 
PBS buffer were incubated 1-1.5 hr with gentle shaking at 
room temperature. 
 Immo-Strep: The surface was washed 3 times by 0.05% 
TPBS (Tween 20 in PBS), and biotinylated peptides in 
0.05% TPBS were incubated 1-1.5 hr with gentle shaking at 
room temperature. 
ELISA 
 To prepare ELISA, the surface with immobilized 
antigens was washed 3 times with 1% TPBS. scFv-phage at 
a concentration of 10
11
 pfu/ml in 1% TPBS was added and 
incubated for 1 hr. After 6 times washing with 1% TPBS, 
1:5000 diluted HRP/anti-M13 phage conjugated antibody in 
3% BSA-PBS was incubated for 1 hr. After 3 times washing 
with 1% TPBS, the phage binding was detected with TMB 
(tetramethylbenzidine). After 10 min, the reaction was 
stopped by the addition of 1M H2SO4. The calculation of 
absorbance was performed by subtracting A620 from A450 
(Thermo Labsystems Multiskan MCC/340). 
Helper Phage ELISA to Detect Peptide Binding Yield on 
Different Solid Surfaces 
 The peptides (5, 20, 100 ug/ml in PBS for Maxisorp, or 
in Na carbonate for Immo-Amino) and two control proteins 
(?s-CN and BSA; 100 ug/ml in PBS) were added into 
microtiter plate and incubated overnight at 4°C. After 3 
times washing with PBS, helper phage at a concentration of 
10
10
-10
11
 pfu/ml in PBS was added and incubated for 1.5 hrs. 
After 6 times washing with 1% TPBS, phage binding was 
detected with ELISA as described above. 
Table 1. The Selected Peptides from ?s1-CN 
 
Name Peptide Sequence MW (g/mol) Amino Acid Residues 
F1 ?s1-CN f17–31 NENLLRFFVAPFPEV 1790.91 15 
F2 ?s1-CN f150–163 FRQFYQLDAYPSGA 1661.77 14 
F3 ?s1-CN f185–199 PIGSENSEKTTMPLW 1591.72 15 
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Biotin-HRP to Detect Biotinylated Peptide Binding Yield 
on Immo-Strep 
 The biotinylated peptides (a series of concentrations in 
0.05% TPBS) and biotin (100 μg/ml in 0.05% TPBS) as 
control were added into Immo-Strep plate and incubated 1.5 
hr at room temperature. After 6 times of washing with 1% 
TPBS, Biotin-HRP (432040, Invitrogen) at a concentration 
of 20 ng/ml in 0.05% TPBS was added and incubated for 1 
hrs. 6 times of washing with 1% TPBS was performed again, 
and the bound Biotin-HRP was detected by TMB and ELISA 
as described above 
Elution Methods 
 Trypsin Elution (TE): After phage incubation and 
washing, 120 μl of 1 mg/ml trypsin in PBS solution was 
incubated onto each well for 10 min at room temperature 
with rotation. The supernatant was collected and used for 
further rounds of panning. The theory behind Trypsin 
Elution is explained above. 
 Background Absorption (BA): After phage incubation 
and washing, 120 μl per well of 0.1 M triethylamine (TEA) 
was added and following incubation for 10 min at room 
temperature with rotation, the TEA solution with the eluted 
phages (8 well replicates, totally 120?8=960 μl) was 
collected and mixed with 0.5 ml of 1 M Tris–HCl, pH 7.4. 
The prepared empty Streptavidin plate (blocked by 200 
μg/ml biotin for 1 hr) was washed with 1% Tween 20 PBS. 
The eluted solution was then added to this empty plate and 
incubated for 1 hr with rotation at room temperature. The 
supernatant was collected and used for further rounds of 
panning. 
 Competitive Elution (CE): After phage incubation and 
washing, 120 μl of 25 μg/ml biotinylated peptide solution 
was incubated onto each well for 1 hr at room temperature 
with rotation. The supernatant was collected and used for 
further rounds of panning. 
 A schematic presentation of the elution methods is shown 
in Fig. (2). 
Optimized Procedure for Panning of Phage Libraries 
Against Small Peptides Immobilized on Immo-Strep 
Surface 
 Tomlinson I and J libraries were used individually in 
parallel to perform the panning. The peptide solution (20 
μg/ml in PBS, pH 7.2) was incubated 1~1.5 hr onto Nunc 
Streptavidin plates with 150 μl per well (each peptide had 8 
replicates). After 3 washes by PBS with 1% TPBS, 120 μl 
scFv phage library (10
12
 -10
13
 cfu/ml) in 1% TPBS was 
added to each well and incubated for 2 hrs. Wells were 
washed with 1% TPBS by 15 times for first round, 21 times 
for second and further round of panning. The bound phage 
was eluted by CE method as described above. For each 
peptide, 8 replicates of eluted phage were collected and 
mixed together. Then 500 μl of the eluted phage was used to 
infect 2 ml of exponential phase growing E. coli TG1, which 
were plated on TYE-Amp-Glu plates (TYE plates containing 
100 mg/ml of ampicillin and 1% glucose) and incubated at 
37°C overnight. The grown colonies were scraped into 4 ml 
of PY–Amp-Glu (PY broth containing 100 mg/ml of 
ampicillin and 1% glucose). 200 μl of this scraped culture 
were used to inoculate 50 ml fresh PY–Glu–Amp and 
incubated with shaking at 37°C for 2 hrs to exponential 
phase. KM13 helper phage (5?1010 pfu) were added to 10 ml 
of each library culture and the mixture incubated at 37°C 
without shaking for 30 min. Infected cells were pelleted, 
resuspended in 50 ml PY–Amp-Glu with 50 μg/ml 
kanamycin, and incubated overnight with shaking at 30°C. 
scFv-phage particles were concentrated to 2 ml from each 
culture supernatant by precipitation with 20 ml polyethylene 
glycol in 2.5 M NaCl as described previously [14]. 
 The concentrated phage were diluted in 1% TPBS (10
12
 -
10
13
 cfu/ml) using for the next round of selection. The phage 
library was subjected to four rounds of panning. The 
monoclonal scFvs were selected by monoclonal ELISA 
according to protocol from scFv-phage libraries’ supplier. 
The monoclonal scFvs was considered positive if absorbance 
value is above 0.350. 
BstN1 DNA Fingerprinting 
 DNA fingerprinting with the BstN1 restriction enzyme 
was used to determine the number of unique clones from the 
monoclonal scFv-phage ELISA. From wells that gave a high 
positive signal in monoclonal ELISA, bacteria (containing 
scFv-DNA in phagemid) were picked and added to 30 μl 
sterile water and incubated in a microwave oven for 1.5 min 
at 700 W. 5 μl was subsequently transferred to 15 μl PCR 
mix containing 2.5U Taq DNA Polymerase (Invitrogen), 0.2 
μM forward primer LMB3 (5’- CAGGAAACAGCTATGAC 
-3’) and 0.2 μM reverse primer pHEN (5’-
CTATGCGGCCCCATTCA-3’), 0.2mM dNTPs, 1.5mM 
MgCl2 and 2 μl 10 ? PCR buffer (Invitrogen). PCR was 
carried out in 30 cycles (45 sec at 94°C, 45 sec at 50°C and 2 
min at 72 
?
C). After amplification, the 1,000-bp scFv-
cassette was digested with the enzyme BstNI (New England 
Biolabs). To 20 μl of the PCR product, the following was 
added: 17.4 μl H2O, 2 μl 10 ? NEB buffer 2, 0.2 μl (2U) 
BstNI and 0.2 μl 10 mg/ml BSA (bovine serum albumin). 
The mix was digested for 2 h at 60°C and restriction patterns 
were analyzed on a 3% agarose gel. 
scFv Gene Sequencing 
 Three to eight clones from each DNA fingerprinting 
patterns were selected, and sequenced by IIT Biotech GmbH 
(Bielefeld, Germany). The bidirectional sequencing were 
performed with two primers LMB3 and pHEN for each 
clone, to ensure that the the scFv gene (1000 bp) were 
sequenced reliably. 
RESULTS 
Identification of Binding Capacity of Different Solid 
Surfaces with Small Peptides 
 Helper phage, detected by HRP / anti-M13 phage 
conjugated antibodies, was used to identify the binding 
capacity of tested surfaces with peptides. The empty surface 
with high absorbance shows that the surface was fully 
occupied by helper phage (Fig. 1A, B). On the contrary, the 
absorbance of surfaces exposed to two control proteins (CN 
and BSA) is low as these proteins prevent the phage from 
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binding to the empty surface. The amount of bound helper 
phage on the Immo-Amino or Maxisorp exposed to three 
peptides (F1, F2, F3) was almost as high as the empty 
surface (Fig. 1A, B), showing that the only a small fraction 
of the surface is occupied by peptides. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Detection of binding capacity of different solid surfaces. 
The unoccupied surface was assayed, which means that a high 
absorbance translates to a poor binding capacity. The binding 
capacity on Maxisorp (A) or Immobilizer Amino (B) surface was 
tested by a helper phage ELISA. Casein and BSA was used as 
positive control and an empty surface as a negative control. Biotin-
HRP was used to detect the binding of biotinylated peptides on 
Immo-Strep (C). Biotin was used as positive control and an empty 
surface as a negative control. The error bars represent the standard 
deviation of 4 replicates. 
 For investigation of binding to the Immo-Strep, Biotin-
HRP was used to detect how much streptavidin already 
occupied by biotinylated peptides. The absorbance value 
represents the amount of Biotin-HRP bound on surface (Fig. 
1C). The empty surface with high absorbance shows that the 
maximal absorbance reached 1.60, when the surface was 
fully occupied by Biotin-HRP. The Biotin-HRP used in the 
test has so strong binding ability to the Immo-Strep that even 
high concentration of biotin (100 μg/ml) could not 
completely block it. Consequently, an absorbance of 0.60 
indicates that all the free streptavidin on the surface have 
been occupied. The absorbance of Biotin-HRP from surfaces 
exposed to biotinylated peptides was similar to absorbance 
of the surface exposed to biotin. This shows that the 
biotinylated peptides have occupied all binding sites of 
streptavidin. 
Methods to Reduce Background Binding (Surface-
Binding scFv-Phages) 
 Based on the above result, Immo-Strep was selected as 
the best surface for immobilization of peptides. However, 
even with Immo-Strep, the original panning procedure with 
the TE method (Fig. 2) was not successful (Table 3), because 
some scFvs (called anti-Polysorp in this study) that 
specifically bind to Polysorp were always dominant in the 
phage population after every cycle of panning. To reduce the 
amount of surface-binding scFv-phages and thereby enhance 
the amount of peptide-binding scFv-phages during panning 
procedure, it was necessary to develop an improved elution 
procedure. Two alternative methods for elution were tested, 
BA and CE as outlined in Fig. (2). 
 Every generated phage sub library by panning on peptide 
was added to both a surface coupled with peptide and an 
empty surface. The relative increase in peptide-binding scFv-
phages was then calculated as the ratio between the two 
numbers (enrichment ratio) and is shown in Table 2. The 
results show that both BA and CE are much better than the 
original TE, because no enrichment is observed with the TE. 
CE is the elution method that has the highest enrichment 
ratio. 
 96 single colonies from the 4
th
 round of panning using 
both CE and BA were selected at random, and tested against 
peptide F2 and empty surface in monoclonal phage ELISA. 
The specific monoclonal peptide-binding scFv-phage could 
be successfully isolated from phage population panned by 
using both BA and CE methods (Table 3). The percent of 
peptide-binding, surface-binding and others binding scFvs in 
total 96 colonies were calculated. It showed that CE had 
higher percent of peptide-binding, lower percent of surface-
binding, which indicates that CE was more effective than 
BA. 
Production of Monoclonal scFv-Phages Against Peptide 
F1 and F3 
 Panning of phage libraries on peptide F1 and F3 was also 
performed using the CE method. The eluted phage from 
peptide-binding or empty surface was titered after each 
round of panning. It was observed that panning of library J 
on both peptide F1 and F3 resulted in a high enrichment ratio 
after 4
th
 panning, whereas panning of library I always had a 
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low enrichment ratio (Table 2). Therefore, only the phage 
population from library J after 4
th
 round of panning was 
selected for the monoclonal phage ELISA. The amount of 
isolated specific monoclonal phages is showed in Table 3. 
From the anti-F3 polyclonal phage sub library, we obtained 
70 of 96 colonies against F3 and only 1 colony against the 
surface. This is corresponding with a high enrichment ratio 
of 290 determined by titering eluted phage (Table 2). 
DNA Fingerprinting and Sequencing of scFv Genes 
 For each group of anti-peptide scFvs, the 29 strongest 
binding clones from the monoclonal ELISA (Table 3) were 
selected, and BstN1 DNA fingerprinting was then applied. 
Based on the restriction enzyme cleavage pattern (Fig. 3), 1 
unique pattern was observed within the 29 anti-F1 scFv-
phages, 2 patterns were revealed within anti-F2 scFv-phages, 
and 4 patterns were revealed within anti-F3 scFv-phages. 
Three to eight clones from each pattern were sequenced 
(Table 4 and Fig. 4), and the pattern 2 of anti-F3 exhibits two 
different scFv sequences, whilst all the other patterns possess 
only one unique scFv sequence. In the following, each 
monoclonal scFv will be abbreviated with the Roman 
numeral of its corresponding group. 
Specificity of Monoclonal scFvs 
 To identify the specificity of the produced anti-peptide 
monoclonal scFv-phages, ELISA was performed on the 
monoclonal scFv-phages against different peptides and 
proteins. All anti-peptide monoclonal scFv-phages showed 
high affinity with their corresponding peptides (Fig. 5A), 
high binding ability with ?s-CN and CN, and no cross-
reaction with the negative controls, BSA and gelatin (Fig. 
5B). The anti-F1 and anti-F2 I scFvs had good specificity 
and very low binding with non-target peptides. The other 
monoclonal scFvs had little cross-reactions with non-target 
peptides. Anti-F3 II had the lowest cross-reaction within the 
anti-F3 scFvs. 
Table 3. Distribution of Binding Profiles for Monoclonal 
scFv-Phages After 4 Rounds of Panning on Peptides 
 
Binding Profile
a
 
Elution
b
 Peptide Library 
Peptide Surface Unknown 
I 0 41 55 
TE F2 
J 0 60 36 
I 0 58 38 
SA F2 
J 55 18 23 
I 60 15 21 
F2 
J 68 11 17 
I / / / 
F1 
J 29 4 63 
I / / / 
CE 
F3 
J 70 1 25 
aThe numbers of isolated monoclonal phages against peptide, empty surface, or 
unknown from 96 random selected single colonies. 
bTE: Trypsin Elution; CE: Competitive Elution; SA: Surface Absorbing. 
DISCUSSION 
 The first requirement for successful generation of anti-
peptide scFv-phage is to permanently immobilize the 
peptides on a solid surface. Small peptides normally do not 
have enough intermolecular attraction forces to exert passive 
adsorption. Although some researchers have used Maxisorp 
for immobilization of small peptides [28-31], we advise 
against this procedure for phage display panning. From our 
experience the small peptides are sometimes difficult to 
immobilize and are easily released from e.g. Maxisorp 
during phage display panning. It is therefore very important 
to check the binding capacity of small peptides to a selected 
surface before panning, e.g by the methods shown in Fig. 
(1). 
 
Table 2. Changing of Enrichment Ratio After Each Round of Panning on Peptides 
 
Enrichment Ratio
a
 After Each Round of Panning 
Elution
b
 Peptide Library 
1 2 3 4 
I 0.9 1.0 0.6 / 
TE  F2 
J 1.1 1.3 0.9 / 
I 1.5 1.2 2.3 1.7 
SA  F2 
J 1.3 2.3 41.4 26.4 
I 0.6 1.2 16.2 46.6 
F2 
J 1.1 2.8 51.8 75.6 
I 1.1 3.2 1.6 5.0 
F1 
J 1.3 5.3 34.8 56.7 
I 1.0 3.0 3.8 7.1 
CE  
F3 
J 0.9 4.0 37.5 290.0 
aThe generated phage sub library after each round of panning on peptide was added to both a surface coupled with peptide and an empty surface. Enrichment ratio was determined by 
the number of eluted phage from peptide coupling surface compared to that from empty surface. 
bTE: Trypsin Elution; CE: Competitive Elution; SA: Surface Absorbing. 
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 We used helper phage to perform the binding capacity 
check in an ELISA. We knew from a previous study that the 
helper phage in PBS (without Tween 20) bind strongly to 
Maxisorp and Polysorp based surfaces and do not detach in 
subsequent washing steps [32]. So, incubation and 
subsequent detection of the helper phage can reveal the level 
of empty positions on a surface already treated with peptides. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Different methods for eluting bound phage. (A) Trypsin Elution (TE): Trypsin cleaves between the scFv and pIII of phage. Thus, all 
the scFvs-attaching phage (both antigen binding and surface binding) can be eluted, whereas phage-head-attaching phage is still bound to on 
surface. (B) Surface Absorption (SA): The eluted phage by TEA (triethylamine) (containing both antigen-binding and surface-binding phage) 
were incubated onto empty solid surface to reduce the surface-binding phage, and then the unbound phage population was collected for next 
panning. (C) Competitive Elution (CE): The elution of bound phages is performed by using high concentration of target antigen. The 
surface-binding phage should still be bound to surface. 
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 With the helper phage ELISA, we could not measure any 
immobilized peptides on Immo-Amino (Fig. 1). As a side 
comment, the peptides immobilized on Immo-Amino and 
Maxisorp could also not be detected by the later generated 
anti-peptide scFv-phages (data not shown), which confirms 
our observation. In contrast, Casey et al. [33, 34] coupled a 
20-mer peptide to Immo-Amino and detected this peptide 
with antibodies. We have also detected very strong binding 
Table 4. Amino Acid Sequences of Selected Monoclonal scFvs 
 
Sequence
b
 
scFv Pattern
a
 Group 
CDRH2 CDRH3 CDRL2 CDRL3 
anti-F1 P1 I SIQQLGRGTLYAD GALSFDY QASRLQS QQNYQLPLT 
anti-F2 P1 I SIQQYGKPTRYAD GSRNFDY HASLLQS QQVGIRPVT 
  P2 II n.ac n.a SASRLQS QQSRTRPTT 
anti-F3 P1 I AIKGQGARTTYAD NYASFDY GASWLQS QQIQKHPAT 
  P2 II SISSQGKITRYAD VDAGFDY NASHLQS QQRTGKPPT 
  P2 III GIRSGGQRTYYAD SKQGFDY TASTLQS QQPIGLPPT 
  P3 IV SIHGNGALTPYAD PYGTFDY GASQLQS QQIEEHPST 
  P4 V SIKSTGGATRYAD DVPKFDY NASSLQS QQRHRFPLT 
anti-Polysorp  I n.a n.a HASNLQS QQQKRRPGT 
  II n.a n.a RASSLQS QQMLRAPRT 
aFrom Fig. (3). 
bThe 18 randomly changed residues are bold and underlined. The complete sequence is shown in Fig. (4). 
cn.a. - not applicable. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). BstNI DNA fingerprinting of unique scFv genes. 29 clones from each group of anti-peptide scFv-phages have been tested. Only 
unique restriction patterns (P1-P4) are shown. M1, O’GeneRuler Express DNA ladder (Fermentas). M2, 100 bp DNA ladder (Invitrogen). 
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ability between the dipeptidase (pepD) of Lactococcus lactis 
and Immo-Amino (results not shown). So our conclusion is 
that the binding between Immo-Amino and peptides/proteins 
are variable, and therefore not universally applicable. 
 Another factor that impairs the successful generation of 
anti-peptide scFv-phage is high non-specific binding and 
background binding scFv-phages. It is therefore necessary to 
reduce both phenomena during the panning. Non-specific 
binding is the binding of phage heads rather than the scFvs 
 
 
GCC ATG GCC GAG GTG CAG CTG TTG GAG TCT GGG GGA GGC TTG GTA CAG CCT GGG 
A M A E V Q L L E S G G G L V Q P G 
                  
GGG TCC CTG AGA CTC TCC TGT GCA GCC TCT GGA TTC ACC TTT AGC AGC TAT GCC 
G S L R L S C A A S G F T F S S Y A 
                  
ATG AGC TGG GTC CGC CAG GCT CCA GGG AAG GGG CTG GAG TGG GTC TCA XXX ATT 
M S W V R Q A P G K G L E W V S X I 
   
 
              
XXX XXX XXX GGT XXX XXX ACA XXX TAC GCA GAC TCC GTG AAG GGC CGG TTC ACC 
X X X G X X T X Y A D S V K G R F T 
                  
ATC TCC AGA GAC AAT TCC AAG AAC ACG CTG TAT CTG CAA ATG AAC AGC CTG AGA 
I S R D N S K N T L Y L Q M N S L R 
              
 
   
GCC GAG GAC ACG GCC GTA TAT TAC TGT GCG AAA XXX XXX XXX XXX TTT GAC TAC 
A E D T A V Y Y C A K X X X X F D Y 
        
 
         
TGG GGC CAG GGA ACC CTG GTC ACC GTC TCG AGC GGT GGA GGC GGT TCA GGC GGA 
W G Q G T L V T V S S G G G G S G G 
      
 
           
GGT GGC AGC GGC GGT GGC GGG TCG ACG GAC ATC CAG ATG ACC CAG TCT CCA TCC 
G G S G G G G S T D I Q M T Q S P S 
                  
TCC CTG TCT GCA TCT GTA GGA GAC AGA GTC ACC ATC ACT TGC CGG GCA AGT CAG 
S L S A S V G D R V T I T C R A S Q 
                  
AGC ATT AGC AGC TAT TTA AAT TGG TAT CAG CAG AAA CCA GGG AAA GCC CCT AAG 
S I S S Y L N W Y Q Q K P G K A P K 
     
 
            
CTC CTG ATC TAT XXX GCA TCC XXX TTG CAA AGT GGG GTC CCA TCA AGG TTC AGT 
L L I Y X A S X L Q S G V P S R F S 
                  
GGC AGT GGA TCT GGG ACA GAT TTC ACT CTC ACC ATC AGC AGT CCG CAA CCT GAA 
G S G S G T D F T L T I S S P Q P E 
          
 
       
GAT TTT GCA ACT TAC TAC TGT CAA CAG XXX XXX XXX XXX CCT XXX ACG TTC GGC 
D F A T Y Y C Q Q X X X X P X T F G 
         
 
        
CAA GGG ACC AAG GTG GAA ATC AAA CGG GCG GCC GCA       
Q G T K V E I K R A A A       
 
Fig. (4). Complete sequence of scFv (gene and amino acid) from Tomlinson I+J library. The TAG stop codon was read as Glutamine because 
scFvs were produced in E. coli TG1 suppressor strain. The scFvs from this library have 18 different positions (marked as X) randomly 
changed at antigen binding regions, i.e. CDRs, which are highlighted. Table 4 shows the actual CDR sequences of representative isolated 
scFvs. The PCR product did not contain heavy chain in this scFv. 
XhoI 
SalI 
NotI 
CDRH2 
CDRH3 
CDRL2 
CDRL3 
NcoI 
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to any components, and we previously demonstrated that 
Tween 20 can reduce most of this non-specific binding [32]. 
Background binding is the binding of scFvs to the 
background matrix, and we found two reasons for a high 
background binding. One is the ratio between the surface 
occupied by the immobilized antigen and the total surface. If 
this ratio is low, the background binding will easily dominate 
the panned phage library [35]. The other reason is that in 
highly diverse antibody phage libraries e.g. large na?ve or 
synthetic libraries [36]. There is a high risk that these 
libraries contain specific antibodies (scFvs) against the 
background matrix. We observed this, and have isolated and 
identified such monoclonal anti-Polysorp scFvs (sequences 
shown in Table 4). This problem has also been found by 
using large na?ve libraries for panning against complex 
antigen targets, such as cells [37-39]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). ELISA for monoclonal anti-peptide scFv-phages against 
different peptides (A) or proteins (B). Biotinylated peptides were 
coupled on Immo-Strep. All proteins were coupled on Immo-
Amino. Roman numeral of each monoclonal scFv is corresponding 
to the group number shown in Table 4. Each error bar represents the 
standard deviation of 4 replicates. 
 In this study, we introduced the concept of enrichment 
ratio (Table 2), which is determined by comparing the titer 
of eluted phage from a peptide-binding surface to the titer 
from an empty surface. An increase in this ratio represents 
the enrichment of peptide-binding scFvs in the produced sub 
phage library. We found that a high enrichment ratio 
determined by titering eluted phage was corresponding to a 
high number of peptide-binding clones determined by 
monoclonal ELISA (Tables 2 and 3). The presented 
enrichment ratio, which only requires a control panning on 
the background, can therefore immediately predict the 
proportion of specific binders in the subsequent generated 
polyclonal phage library. This is an advantage, compared to 
the normal procedure, where ELISA is always used to detect 
the specificity of the generated polyclonal phage library 
toward target antigen. This ELISA procedure requires extra 
work in the laboratory as well as waiting time for producing 
the polyclonal phage library. 
 There are basically four methods to reduce the 
background binding during the panning of an antibody phage 
library. We investigated two methods: i) BA method, which 
was also performed by Portolano et al. [40] and Krichevsky 
et al. [41], and ii) CE method, which was proved to be 
applicable by Meulemans et al. [42] and Heiskanen et al. 
[43]. We found that CE provided a stronger enrichment than 
BA, and was adequate for our purpose. Two other methods 
have been mentioned in literatures, iii) Antigen modification 
method [44-46], and iv) Alternate background panning [47, 
48], but were not tested in this study. 
 We focused on solid surface supported panning method, 
which is similar to standard ELISA assays. Some researchers 
used another panning method called solution panning for 
developing the antibodies against small peptides [49-52]. 
The solution panning mixes the phage library with 
biotinylated peptides in buffer solution, and bound phages 
are collected from the solution after a short (15 min) 
incubation with streptavidin beads. Apparently, the short 
time incubation for streptavidin-biotin binding should reduce 
background binding phages. However, we tried solution 
panning with Immo-Strep to collect bound phage and found 
that background binding (Polysorp surface binding) phage 
was still dominant in the panned phage population (results 
not shown). We did not test streptavidin beads in our study, 
but the basic material of the magnetic beads and Polysorp 
surface are both polystyrene, so there is a pronounced risk 
that some scFvs in the library could also specifically bind to 
the beads’ polystyrene material. Therefore, successful 
selection of phages against our selected peptides is still 
dependent on methods to reduce the background binding. 
 In summary, we have optimized the method to select 
monoclonal scFvs from a large synthetic antibody phage 
display library against small peptides immobilized on solid 
surface. This was achieved by developing a method for 
detecting the efficiency of immobilization of small peptides 
and selecting the best method for excluding the background 
binding scFv-phage. Apart from the specific antibodies 
raised in this study, it is our belief, that the methods 
developed are universally applicable for anyone interested in 
selecting antibodies (antibody fragments) against small 
peptides by antibody phage display. 
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ABBREVIATION 
scFv = Single chain variable fragment of  
   antibody 
PBS = Phosphate buffered saline 
F1, F2, F3 = Synthetic peptides from ?s1-casein  
   sequence 
F1 = f17–31 (NENLLRFFVAPFPEV) 
F2 = f150–163 (FRQFYQLDAYPSGA) 
F3 = f185–199 (PIGSENSEKTTMPLW) 
CDR = Complementary determining regions of  
   antibody 
TPBS = Tween 20 in PBS 
Immo-Amino = Nunc Immobilizer Amino surface 
Immo-Strep = Nunc Immobilizer Sreptavidin surface 
CN = Casein 
HRP = Horse radish peroxidase 
MW = Molecular Weight 
TE = Trypsin Elution 
CE = Competitive Elution 
BA = Background Absorption 
TEA = Triethylamine 
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